男学院
发表于 2025-3-28 17:18:27
http://reply.papertrans.cn/64/6318/631758/631758_41.png
prostate-gland
发表于 2025-3-28 18:59:13
http://reply.papertrans.cn/64/6318/631758/631758_42.png
法官
发表于 2025-3-28 23:25:23
Tissue Engineered Models to Study Bone Metastasis and Metastatic Bone Diseasethat 350,000 people die annually as a result of bone metastasis in the United States . Survival rates of MBD are generally low but vary depending on the primary cancer site. Primary breast, lung, and prostate cancer account for 70% of MBD cases . Additionally, the economic burden for patients
propose
发表于 2025-3-29 05:52:02
Biology of Bone Cancer Painnts with skeletal metastases and is directly proportional to the patient’s quality of life, clinical advancements in the treatment of bone cancer pain are of the utmost importance. Research targeting pain-related cytokines, anti-osteoclastic medications, and ion channels has shown significant clinic
nerve-sparing
发表于 2025-3-29 08:19:48
Breast Cancer Bone Metastasesic involvement, which may lead to considerable pain and morbidity. Skeletal-related events quantify the morbidity of bony metastasis and include pathologic fracture, spinal cord compression, or the need for radiation or surgery for bony metastasis. Some studies included hypercalcemia of malignancy a
清唱剧
发表于 2025-3-29 11:28:15
http://reply.papertrans.cn/64/6318/631758/631758_46.png
anus928
发表于 2025-3-29 17:58:11
http://reply.papertrans.cn/64/6318/631758/631758_47.png
记忆法
发表于 2025-3-29 19:52:06
http://reply.papertrans.cn/64/6318/631758/631758_48.png
Rejuvenate
发表于 2025-3-30 01:12:44
Thyroid Cancer Bone Metastasisroid hormone suppression are considered first-line treatment; however, bony metastases are relatively resistant to these treatment modalities. Medical therapy, surgical resection, and radiation are often necessary to treat progressive or symptomatic lesions and can be utilized as monotherapies or in
正常
发表于 2025-3-30 05:49:53
Introduction to Multiple Myeloma and Multiple Myeloma Bone Diseaseid cells in the bone marrow . The median age at diagnosis is 69, and it most frequently is diagnosed among those aged 65–74 years. There will be an estimated 34,470 new cases of MM in 2022, accounting for 1.8% of all new cancer cases in 2022 and approximately 10–15% of all hematologic malignan